Jyoti Joshi

Datos Biográficos

ID7797150
NOMBREJyoti Joshi
NOMBRESJyoti
APELLIDOJoshi
FIRMAJOSHI J
AFILIACIONESCenter for Disease Dynamics, Economics and Policy, Silver Spring, Maryland, USA
ORCID0000-0002-0971-7257
VERIFICADOSí
TOTAL DE OBRAS4
TOTAL DE CITAS0
TOTAL COMO AUTOR4
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2020
AÑO MÁS RECIENTE DE PUBLICACIÓN2025
ÍNDICE H0

  • Serial C-Reactive Protein Point-of-Care testing to optimize antibiotic treatment in hospitalized children with signs of infection in Zanzibar

    Open AccessDaniel Joshua, Hanna Rahimi et al.ARTICLEPLOS Global Public Health2025

    Bacterial infections are among the leading causes of morbidity and mortality in children, especially in low- and middle- income countries. As a result, antibiotics are frequently prescribed to children with signs of infection, even when cause may not be bacterial. This contributes to antimicrobial resistance (AMR), a global health concern. Integrating serial CRP point-of-care testing with culture and susceptibility testing may improve decision-ma…

  • Operationalising the “One Health” approach in India

    Open AccessFestus A Asaaga, J C Young et al.ARTICLEBMC Public Health2021

    Our findings point to the importance of strengthening existing national policy frameworks as a first step for leveraging cross-sectoral capacity for improved disease surveillance and interventions. This requires the contextual adaptation of the One Health approach in a manner that is sensitive to the underlying socio-political, institutional and cultural context that determines and shapes outcomes of cross-sector collaborative arrangements

  • Estimating the cost of interventions to improve water, sanitation and hygiene in healthcare facilities across India

    Open AccessKatie K Tseng, Natalio Blanco et al.ARTICLEBMJ Global Health2020

    Improving IPC in Indian public HCFs can aid in the prevention of HAIs to reduce the spread of antimicrobial resistance. Although WASH is a necessary component of IPC, coverage remains low in HCFs in India. Using ex-post costs, our results estimate the investment levels needed to improve WASH across the Indian public healthcare system and provide a basis for policymakers to support IPC-related National Action Plan activities for antimicrobial resi…

  • Using ‘smart regulation’ to tackle antimicrobial resistance in low-income and middle-income countries

    Open AccessGerard Porter, Jyoti Joshi et al.ARTICLEBMJ Global Health2020

    Low-income and middle-income countries are aligning their National Action Plans on antimicrobial resistance with WHO's 2015 Global Action Plan. Regulation is a key tool for operationalising national standards aimed at optimising the use of antimicrobial medicines. On its own, the traditional command-and-control approach to regulation is poorly suited to this challenge. 'Smart regulation' can be used to supplement, finetune and improve on more tra…